網頁2024年10月25日 · STELARA is approved in the United States for the treatment of: 1) adults and children six years and older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy; 2) adult patients (18 years or older) with active psoriatic arthritis, used alone or in combination with methotrexate (MTX); 3) adult … 網頁Clinical Review Report: Ustekinumab (Stelara/Stelara I.V.): Janssen Inc [Internet] This review aims to evaluate the beneficial and harmful effects of ustekinumab IV infusion …
Clinical Review Report: Ustekinumab (Stelara/Stelara I.V.) - NCBI …
網頁Ustekinumab (Stelara) intravenous is considered medically necessary when ONE of the following is met: 1. Crohn’s Disease. Individual meets ALL of the following criteria: A. 18 years of age or older B. Medication will be used as induction therapy 網頁Results from the maintenance phase of the Phase 3 study demonstrated that 44 percent of adult patients with moderate to severe ulcerative colitis receiving STELARA SC injections every 8 weeks (q8w) and 38 percent receiving STELARA SC injections every 12 weeks (q12w) achieved clinical remission, as defined by the Mayo score 1, at week 44 (52 weeks … dak auto bakery bread machine
STELARA 130 mg concentrate for solution for infusion
網頁2015年10月19日 · At week 6, 52 percent of patients receiving STELARA ® 130 mg and 56 percent of patients receiving STELARA® ~6 mg/kg achieved clinical response, as … 網頁Following induction therapy with the IV product, the recommended maintenance is Stelara for subcutaneous (SC) injection, given as a 90 mg SC injection administered 8 weeks … 網頁Psoriatic arthritis Initially 45 mg SC, followed by 45 mg dose 4 wk later, then every 12 wk thereafter, or 90 mg for body wt >100 kg. Crohn's disease & ulcerative colitis Induction: Patient >85 kg 520 mg single IV infusion over at least 1 hr, >55 kg-≤85 kg 390 mg single IV infusion over at least 1 hr, ≤55 kg 260 mg single IV infusion over ... biotech tracker